Pfizer RSV vaccine may protect high-risk adults ages 18-59
Respiratory syncytial virus – viral vaccine under research Hailshadow | Istock | Getty Images A vaccine from Pfizer showed the potential to protect adults ages 18 to 59 who are…
2024-05-06 06:26:58
Respiratory syncytial virus – viral vaccine under research Hailshadow | Istock | Getty Images A vaccine from Pfizer showed the potential to protect adults ages 18 to 59 who are…
Jonathan Raa | Nurphoto | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Hi folks! Two competing cell…
This story is part of CNBC’s quarterly Cities of Success series, which explores cities that have transformed into business hubs with an entrepreneurial spirit that has attracted capital, companies and…
Cannabis plants grow in the clone room at Aurora Deutschland GmbH, a manufacturer of medical Cannabis products, in Leuna, Germany September 11, 2023. Lisi Niesner | Reuters Growing cannabis indoors…
The coronal view of a human brain of a patient suffering from Parkinson’s disease Sherbrooke Connectivity Imaging Lab | Getty Images A highly popular class of drugs for diabetes and…
People sitting by a pier during sunset in Singapore. Roslan Rahman | Afp | Getty Images Singapore’s economic losses due to heat stress could nearly double to $1.64 billion in…
Artist Refik Anadol uses generative AI to produce images, seen here as part of the “Echoes of the Earth: Living Archive” exhibition at Serpentine North, London. Hugo Glendinning | Courtesy…
A nurse fills a syringe with Moderna Covid-19 vaccine. Fred Tanneau | Afp | Getty Images Moderna on Tuesday said a new version of its Covid vaccine triggered a stronger…
Daniel Grill | Tetra Images | Getty Images Altimmune on Wednesday said its experimental drug helped patients shed weight but also minimized the loss of muscle mass in a midstage…
Nikos Pekiaridis | Lightrocket | Getty Images Moderna has more to offer beyond its Covid vaccine. The biotech company Wednesday announced positive clinical trial data on three experimental vaccines against…